Brooks Laboratories Ltd

Thu 1/10/2026,15:54:1 | NSE : BROOKS

₹54.80-1.00 (-1.79%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 55.52

Previous Close

₹ 55.80

Volume

34254

Mkt Cap ( ₹ Cr)

₹ 161.43

High

₹ 57.00

Low

₹ 52.97

52 Week High

₹ 138.34

52 Week Low

₹ 36.30

Book Value Per Share

₹ 42.12

Dividend Yield

0.00

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Brooks Laboratories Ltd

Your Vote -

Buy

22.22%

Hold

5.56%

Sell

72.22%

22.22%

36 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

54.80

678

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

678

Option Chain

Analyzes market sentiment, predicts Brooks Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Brooks Laboratories - Trading Window

    22 Sep 2026, 6:33PM Brooks Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulatio
  • Brooks Laboratories - Resignation

    16 Sep 2026, 7:07PM Brooks Laboratories Limited has informed the Exchange regarding Resignation of Ms Krutika Rane as Company Secretary and Compliance Officer of the Comp
  • Brooks Laboratories - Resignation of Director/KMP/SMP

    16 Sep 2026, 6:58PM Brooks Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMP
  • Brooks Laboratories - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    16 Sep 2026, 6:46PM Resignation of Ms. Krutika Rane as Company Secretary and Compliance Officer of the Company with effect from 9th October 2026.
  • Brooks Laboratories - Copy of Newspaper Publication

    16 Sep 2026, 1:17PM Newspaper Publication regarding re-lodgement of transfer deed.
  • Brooks Laboratories - Shareholders meeting

    4 Sep 2026, 8:40PM Brooks Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 03, 2026. Further, the c
  • Brooks Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    4 Sep 2026, 8:36PM Scrutinizer Report alongwith voting results for the AGM held on September 3, 2026.
  • Brooks Laboratories - Shareholders meeting

    3 Sep 2026, 3:59PM Brooks Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 03, 2026
  • Brooks Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    4 Sep 2026, 8:36PM Scrutinizer Report alongwith voting results for the AGM held on September 3, 2026.
  • Brooks Laboratories - Shareholder Meeting / Postal Ballot-Outcome of AGM

    3 Sep 2026, 3:52PM Proceedings of the 24th AGM held on Thursday, September 3, 2026.
  • Brooks Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    4 Sep 2026, 8:36PM Scrutinizer Report alongwith voting results for the AGM held on September 3, 2026.
  • Brooks Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    4 Sep 2026, 8:36PM Scrutinizer Report alongwith voting results for the AGM held on September 3, 2026.
  • Brooks Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    4 Sep 2026, 8:36PM Scrutinizer Report alongwith voting results for the AGM held on September 3, 2026.
  • Brooks Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    4 Sep 2026, 8:36PM Scrutinizer Report alongwith voting results for the AGM held on September 3, 2026.
  • Brooks Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    4 Sep 2026, 8:36PM Scrutinizer Report alongwith voting results for the AGM held on September 3, 2026.
  • Brooks Laboratories - Copy of Newspaper Publication

    22 Aug 2026, 2:11PM Please find enclosed herewith Addendum to the Notice of 24th Annual General Meeting.
  • Brooks Laboratories - Shareholders meeting

    21 Aug 2026, 5:10PM Addendum to the Notice of 24th Annual General Meeting of the Company.
  • Brooks Laboratories - Addendum To The Notice Of 24Th Annual General Meeting Of The Company.

    21 Aug 2026, 4:54PM Please find attached addendum to the notice of 24th Annual General Meeting.
  • Brooks Laboratories - Reg. 34 (1) Annual Report.

    21 Aug 2026, 4:51PM Addendum to the Notice of 24th Annual General Meeting of the Company.
  • Brooks Laboratories - Updates

    17 Aug 2026, 7:06PM Brooks Laboratories Limited has informed the Exchange regarding 'Intimation Of Record Date, E-Voting Dates And Book Closure Date'.
  • Brooks Laboratories - Intimation Of Record Date, E-Voting Dates And Book Closure Date

    17 Aug 2026, 6:50PM Intimation of Record date, E-Voting dates and Book Closure date.
  • Brooks Laboratories - Copy of Newspaper Publication

    14 Aug 2026, 5:44PM Brooks Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
  • Brooks Laboratories - Outcome of Board Meeting

    13 Aug 2026, 8:04PM Brooks Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
  • Brooks Laboratories - Results - Financial Results For June 30, 2026.

    13 Aug 2026, 7:55PM Financial Results for quarter ended June 30,2026.
  • Brooks Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, 13Th August, 2026

    13 Aug 2026, 7:50PM Outcome of Board Meeting held on Thursday, 13th August, 2026
  • Brooks Laboratories - Copy of Newspaper Publication

    13 Aug 2026, 3:41PM Newspaper publication regarding 24th AGM of the Company to be held on 3rd September 2026.
  • Brooks Laboratories - General Updates

    12 Aug 2026, 6:33PM Letter to Shareholders - Annual Report for the FY 2025-26.
  • Brooks Laboratories - Shareholders meeting

    12 Aug 2026, 6:31PM Brooks Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 03, 2026
  • Brooks Laboratories - Letter To The Shareholders - Annual Report For The FY 2025-26.

    12 Aug 2026, 6:15PM Letter to the Shareholders-Annual Report for the FY 2025-26
  • Brooks Laboratories - Shareholder Meeting- AGM On 3Rd September 2026.

    12 Aug 2026, 6:10PM Notice of 24th Annual General Meeting of the Company to be held on 3rd September 2026 through VC/OAVM.
  • Brooks Laboratories - Reg. 34 (1) Annual Report.

    12 Aug 2026, 6:05PM Pursuant to Regulation 34 read with Regulation 30 of SEBI Listing Regulations, we are enclosing herewith the following: 1. Notice of the AGM.2. Annual
  • Brooks Laboratories - Copy of Newspaper Publication

    7 Aug 2026, 5:49PM Intimation of 24th Annual General Meeting of the Company through VC/OAVM.
  • Brooks Laboratories - Board Meeting Intimation for Under Regulation 29 Of The SEBI (Listing Obligation And Disclosure Require

    6 Aug 2026, 7:10PM Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider
  • Brooks Laboratories - Appointment

    17 Jul 2026, 5:41PM Appointment of Mr. Rajesh Mahajan as President - Trading w.e.f. July 17, 2026.
  • Brooks Laboratories - Announcement under Regulation 30 (LODR)-Change in Management

    17 Jul 2026, 5:30PM Appointment of Mr. Rajesh Mahajan as President - Trading.
  • Brooks Laboratories - Agreements

    16 Jul 2026, 6:35PM Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
  • Brooks Laboratories - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    16 Jul 2026, 6:26PM We hereby inform that, further to the disclosure made by the Company on 19th June 2026 regarding proposed sale of a portion of its shareholding in Bro
  • Brooks Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jul 2026, 3:38PM Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June 2026.
  • Brooks Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    9 Jul 2026, 4:00PM As of June 2026, 52.62% is owned by Indian Promoters and 47.38% by Public. <p align=justify> Top five Promoters holding highest number of shares of Br
  • Brooks Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Jul 2026, 3:22PM Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018 for quarter ended 30th June 2026.

Key fundamentals

Evaluate the intrinsic value of Brooks Laboratories Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 128.1216 121.133 74.5735 62.4424 69.9259
Liabilities 128.1216 121.133 74.5735 62.4424 69.9259
Equity 29.4572 29.4572 26.2467 24.7028 24.7028
Gross Profit 7.0597 4.9743 3.2173 -5.8143 1.8744
Net Profit 5.805 3.0522 1.5287 -8.1912 0.666
Cash From Operating Activities 9.2934 2.6263 -9.6806 0.5622 3.1235
NPM(%) 6.77 3.69 1.92 -14.74 0.86
Revenue 85.7384 82.5568 79.4861 55.538 76.9672
Expenses 78.6787 77.5825 76.2688 61.3523 75.0928
ROE(%) 4.67 2.45 1.23 -6.6 0.53

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Brooks Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 856.70 -1.78 21.67 31.49 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 115.68 -0.18 1652.57 114.73 0.39 0.00
Vaishali Pharma Ltd 8.38 0.36 26.19 719.76 15.42 0.00
Astec Lifesciences Ltd 708.60 -1.96 0.00 122.93 -363.14 0.00

Company Info

Our Company was incorporated vide a Certificate of Incorporation dated January 23, 2002 bearing CIN No. U24232PB2002PLC24910 under the Companies Act 1956 with the name `Brooks Laboratories Limited' by our promoters Mr. Atul Ranchal & Mr. Rajesh Mahajan. We received our certificate of commencement of business on February 19, 2002, from the Registrar of Companies, Punjab, Himachal Pradesh & Chandigarh at Jalandhar. Our Company was initially promoted for manufacturing of latest molecules in Injectables, tablets and dry syrups for the domestic customers. Our Company set up a facility for manufacturing Tablets, Dry Syrup and Injectables, which was supported by a research and development ("R&D") centre at Baddi, Himachal Pradesh. Our Company started its commercial production in the month of June 2006. Our Company became profitable from the very first year of its production. This facility at Baddi is WHO-GMP and ISO 9001:2008 certified. The facility focuses on developing latest molecules in the niche segments and then selling it to various pharmaceutical marketing Companies. Before staring our company, our promoters were engaged in manufacturing of Pharmaceutical Formulations in their partnership firm namely Brooks Pharmaceuticals. The firm had a manufacturing facility at F-94, Industrial Area, Phase 7, Mohali, Punjab. The factory at Mohali had annual installed capacity of 30 Lacs Injectables, 300 Lacs Tablets and 15 Lacs Dry Syrups. Our promoters had a successful track record of running the manufacturing of formulations in the aforesaid firm, profitably for over 6 years. In order to take an advantage of the growing market and avail the tax and other benefits that were made available by the Government to set up a manufacturing facility at Baddi, our promoters decided incorporate our company Brooks Laboratories Ltd and set up a bigger and more sophisticated unit at Baddi, in Himachal Pradesh. Subsequently, the firm was dissolved in the month of December 2008. Further in years 2007 and 2008 to have a smooth transition from Brook Pharmaceuticals to Brooks Laboratories Ltd., Our Company paid/settled some dues to Creditors and Lenders of Brooks Pharmaceuticals aggregating to Rs. 151.79 Lacs. Later on to settle the above our Company purchased on book value certain assets (Fixed assets & Stocks) aggregating to Rs. 113.27 Lacs and received an aggregate sum of Rs. 38.52 Lacs from M/s. Brooks Pharmaceuticals, a partnership firm promoted by our Promoters, Mr. Atul Ranchal and Mr. Rajesh Mahajan. Key Events and Milestones January 23, 2002 Incorporation of Brooks Laboratories Limited. February 19,2002 Received certificate for commencement of business May 5, 2005 Commenced setting up of manufacturing facility at Baddi, Himachal Pradesh. April 10,2006 Manufacturing drugs license issued by the State Drugs Controlling and Licensing Authority, HP. April 30, 2005 Commissioning of R&D centre at Baddi May 20,2006 Completion of Commissioning of plant for manufacture of Tablets, capsules, Injections, Oral Liquids etc. May 30, 2006 Start of commercial production June 1, 2006 First PPI Formulation developed by the Company. October 27,2006 Obtained Import license from Drugs Controller General of India under the Drugs Act 1940 and Drugs Rules. August 02, 2007 Received an AS/NZS ISO 9001:2000 Certificate from SAI Global Certification Services Pty Limited, Australia. April 30, 2008* Takeover of some of the Assets of M/s Brooks Pharmaceuticals, a partnership firm of Our Promoters Mr. Atul Ranchal & Mr. Rajesh Mahajan by our Company. December 30, 2008 Dissolution of M/s Brooks Pharmaceuticals, a partnership firm of Our Promoters Mr. Atul Ranchal & Mr. Rajesh Mahajan. January 06,2009 Micro Small Medium Enterprise (MSME) Registration Certificate issued by Directorate of Industries for Manufacturing/Assembling Injections, Capsules & Tabulates (Single Window Clearance Agency). April 7,2010 The manufacturing facility at Baddi was certified as WHO GMP compliant by Department of Health & Family Welfare, HP. July 27,2010 Received an ISO 9001:2008 Certificate from UKAS Quality Management, URS & IAF. 2012 --Registered Office of the Company has been shifted to Village Kishanpura, Nalagarh Road, Baddi, Distt. Solan, H.P 2013 -Mr. Bhaskar Sharma has been appointed as Additional Independent Director of the company. 2014 - Ms.Sonia Gupta has been appointed as Independent Director of the Company. 2015 -Brooks Laboratories - Shifting of Corporate Office to 5th Floor, Next to Hotel Courtyard Marriott, Andheri Kurla Road, Mumbai - 400093. 2016 -Brooks Laboratories gets manufacturing licence for Gujarat facility. 2023 -The company issued rights shares of Rs. 10 in the ratio of 1:16 at a premium of Rs. 65 per share.

Our Company was incorporated vide a Certificate of Incorporation dated January 23, 2002 bearing CIN No. U24232PB2002PLC24910 under the Companies Act 1956 with the name `Brooks Laboratories Limited' by our promoters Mr. Atul Ranchal & Mr. Rajesh Mahajan. We received our certificate of commencement of business on February 19, 2002, from the Registrar of Companies, Punjab, Himachal Pradesh & Chandigarh at Jalandhar. Our Company was initially promoted for manufacturing of latest molecules in Injectables, tablets and dry syrups for the domestic customers. Our Company set up a facility for manufacturing Tablets, Dry Syrup and Injectables, which was supported by a research and development ("R&D") centre at Baddi, Himachal Pradesh. Our Company started its commercial production in the month of June 2006. Our Company became profitable from the very first year of its production. This facility at Baddi is WHO-GMP and ISO 9001:2008 certified. The facility focuses on developing latest molecules in the niche segments and then selling it to various pharmaceutical marketing Companies. Before staring our company, our promoters were engaged in manufacturing of Pharmaceutical Formulations in their partnership firm namely Brooks Pharmaceuticals. The firm had a manufacturing facility at F-94, Industrial Area, Phase 7, Mohali, Punjab. The factory at Mohali had annual installed capacity of 30 Lacs Injectables, 300 Lacs Tablets and 15 Lacs Dry Syrups. Our promoters had a successful track record of running the manufacturing of formulations in the aforesaid firm, profitably for over 6 years. In order to take an advantage of the growing market and avail the tax and other benefits that were made available by the Government to set up a manufacturing facility at Baddi, our promoters decided incorporate our company Brooks Laboratories Ltd and set up a bigger and more sophisticated unit at Baddi, in Himachal Pradesh. Subsequently, the firm was dissolved in the month of December 2008. Further in years 2007 and 2008 to have a smooth transition from Brook Pharmaceuticals to Brooks Laboratories Ltd., Our Company paid/settled some dues to Creditors and Lenders of Brooks Pharmaceuticals aggregating to Rs. 151.79 Lacs. Later on to settle the above our Company purchased on book value certain assets (Fixed assets & Stocks) aggregating to Rs. 113.27 Lacs and received an aggregate sum of Rs. 38.52 Lacs from M/s. Brooks Pharmaceuticals, a partnership firm promoted by our Promoters, Mr. Atul Ranchal and Mr. Rajesh Mahajan. Key Events and Milestones January 23, 2002 Incorporation of Brooks Laboratories Limited. February 19,2002 Received certificate for commencement of business May 5, 2005 Commenced setting up of manufacturing facility at Baddi, Himachal Pradesh. April 10,2006 Manufacturing drugs license issued by the State Drugs Controlling and Licensing Authority, HP. April 30, 2005 Commissioning of R&D centre at Baddi May 20,2006 Completion of Commissioning of plant for manufacture of Tablets, capsules, Injections, Oral Liquids etc. May 30, 2006 Start of commercial production June 1, 2006 First PPI Formulation developed by the Company. October 27,2006 Obtained Import license from Drugs Controller General of India under the Drugs Act 1940 and Drugs Rules. August 02, 2007 Received an AS/NZS ISO 9001:2000 Certificate from SAI Global Certification Services Pty Limited, Australia. April 30, 2008* Takeover of some of the Assets of M/s Brooks Pharmaceuticals, a partnership firm of Our Promoters Mr. Atul Ranchal & Mr. Rajesh Mahajan by our Company. December 30, 2008 Dissolution of M/s Brooks Pharmaceuticals, a partnership firm of Our Promoters Mr. Atul Ranchal & Mr. Rajesh Mahajan. January 06,2009 Micro Small Medium Enterprise (MSME) Registration Certificate issued by Directorate of Industries for Manufacturing/Assembling Injections, Capsules & Tabulates (Single Window Clearance Agency). April 7,2010 The manufacturing facility at Baddi was certified as WHO GMP compliant by Department of Health & Family Welfare, HP. July 27,2010 Received an ISO 9001:2008 Certificate from UKAS Quality Management, URS & IAF. 2012 --Registered Office of the Company has been shifted to Village Kishanpura, Nalagarh Road, Baddi, Distt. Solan, H.P 2013 -Mr. Bhaskar Sharma has been appointed as Additional Independent Director of the company. 2014 - Ms.Sonia Gupta has been appointed as Independent Director of the Company. 2015 -Brooks Laboratories - Shifting of Corporate Office to 5th Floor, Next to Hotel Courtyard Marriott, Andheri Kurla Road, Mumbai - 400093. 2016 -Brooks Laboratories gets manufacturing licence for Gujarat facility. 2023 -The company issued rights shares of Rs. 10 in the ratio of 1:16 at a premium of Rs. 65 per share.

Parent Organisation

Brooks Laboratories Ltd.

Founded

23/01/2002

Managing Director

NSE Symbol

BROOKSEQ

FAQ